Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study)

C. Warren Olanow, Philippe Damier, Christopher G. Goetz, Thomas Mueller, John Nutt, Olivier Rascol, Alexandru Serbanescu, Frieda Deckers, Hermann Russ

Research output: Contribution to journalArticle

155 Scopus citations
Original languageEnglish (US)
Pages (from-to)58-62
Number of pages5
JournalClinical Neuropharmacology
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2004

Keywords

  • Parkinson disease
  • SPLENDID
  • Sarizotan

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this